Safety of antenatal predniso(lo)ne and dexamethasone on fetal, neonatal and childhood outcomes: a systematic review.
Elise Margaretha Adriana SlobJacqueline U M TermoteJanna W NijkampHetty J Van der KampErica L T van den AkkerPublished in: The Journal of clinical endocrinology and metabolism (2023)
Based on the limited evidence found in this systematic review, predniso(lo)ne may have less side-effects compared to dexamethasone in short- and long-term outcomes. Current literature shows minimal risk of side-effects in the newborn by administration of a prenatal predniso(lo)ne dose of up to 10 mg per day.